Brian Burkavage
Comptroller/Controller/Auditor en IO BIOTECH, INC. .
Fortuna: 16 675 $ al 30/04/2024
Perfil
Brian Burkavage is currently the Chief Accounting Officer at IO Biotech, Inc. He previously worked as the Director-Financial Planning & Analysis at Aclaris Therapeutics, Inc. from 2017 to 2020 and as the Controller at Passage Bio, Inc. from 2020 to 2021.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
IO BIOTECH, INC.
0.02% | 15/03/2024 | 11 500 ( 0.02% ) | 16 675 $ | 30/04/2024 |
Cargos activos de Brian Burkavage
| Empresas | Cargo | Inicio |
|---|---|---|
| IO BIOTECH, INC. | Comptroller/Controller/Auditor | 09/05/2022 |
Antiguos cargos conocidos de Brian Burkavage.
| Empresas | Cargo | Fin |
|---|---|---|
| PASSAGE BIO, INC. | Comptroller/Controller/Auditor | 01/01/2021 |
| ACLARIS THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2020 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| IO BIOTECH, INC. | Health Technology |
| PASSAGE BIO, INC. | Health Technology |
| ACLARIS THERAPEUTICS, INC. | Health Technology |
- Bolsa de valores
- Insiders
- Brian Burkavage
